Trials / Not Yet Recruiting
Not Yet RecruitingNCT07084519
Hypofractionated vs Conventional RT After Prosthetic Breast Reconstruction
Randomized Controlled Trial of Postmastectomy Hypofractionated Radiotherapy Versus Conventional Fractionated Radiotherapy in Breast Cancer Patients Undergoing Prosthetic Breast Reconstruction
- Status
- Not Yet Recruiting
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 190 (estimated)
- Sponsor
- Cancer Institute and Hospital, Chinese Academy of Medical Sciences · Academic / Other
- Sex
- Female
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
This study investigates the safety and efficacy of hypofractionated radiotherapy (HFRT) versus conventional fractionated radiotherapy (CFRT) in breast cancer patients undergoing total mastectomy with prosthetic reconstruction. Study Design Population: Patients with high-risk breast cancer after mastectomy and immediate implant reconstruction. Intervention: HFRT Arm: 43.5 Gy in 15 fractions (2.9 Gy/fraction, 3 weeks). Control Arm: CFRT (50 Gy in 25 fractions, 2 Gy/fraction, 5 weeks). Endpoints Primary: Reconstruction failure rate (e.g., implant removal, capsular contracture)
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| RADIATION | hypofractionated radiotherapy | 43.5 Gy in 15 fractions (2.9 Gy/fraction, 3 weeks) |
| RADIATION | conventional fractionated radiotherapy | 50 Gy in 25 fractions, 2 Gy/fraction, 5 weeks |
Timeline
- Start date
- 2025-08-10
- Primary completion
- 2025-12-31
- Completion
- 2030-12-31
- First posted
- 2025-07-24
- Last updated
- 2025-07-24
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT07084519. Inclusion in this directory is not an endorsement.